GEHC monthly performance report
Monthly GEHC research: returns, drawdown, relative strength, seasonality, and key stats.
GEHC monthly report
—
Key takeaways
- GE HealthCare (GEHC) closed August 2026 at $70.24, up 3.26% for the month and −0.71% over the trailing 12 months.
- Year-to-date, GEHC is −14.36%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −4.12% versus its 200-day moving average ($73.26), a cautious technical signal.
- Over the past three years, GEHC has underperformed the S&P 500 by −79.74%, with a relative strength index reading of 54.4.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
GE HealthCare ended August 2026 at $70.24, posting a monthly return of +3.26%. The S&P 500 returned +3.05% over the same window, leaving relative performance at +0.22%.
The current quarter stands at +6.43% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −4.12% versus the 200-day moving average ($73.26).
Year-to-date, GEHC is −14.36% against SPY +12.89%, a gap of −27.25%. The stock is currently −21.76% below its 52-week high, with maximum 3-year drawdown at −37.41%.
| Period | GEHC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.03% | −0.20% | +0.17% |
| 1 Week | +9.56% | +3.90% | +5.66% |
| 1 Month | +3.26% | +3.05% | +0.22% |
| 3 Months | +15.45% | +7.11% | +8.34% |
| 6 Months |